| __timestamp | ADMA Biologics, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 40786000 |
| Thursday, January 1, 2015 | 6745968 | 47876000 |
| Friday, January 1, 2016 | 8494742 | 52035000 |
| Sunday, January 1, 2017 | 18092835 | 55348000 |
| Monday, January 1, 2018 | 22502922 | 65276000 |
| Tuesday, January 1, 2019 | 25910757 | 82720000 |
| Wednesday, January 1, 2020 | 35050817 | 89118000 |
| Friday, January 1, 2021 | 42896889 | 181193000 |
| Saturday, January 1, 2022 | 52458024 | 174078000 |
| Sunday, January 1, 2023 | 59020000 | 184232000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: ADMA Biologics, Inc. and Veracyte, Inc., from 2014 to 2023. Over this period, Veracyte, Inc. consistently outpaced ADMA Biologics, Inc. in SG&A spending, with a peak in 2023 where Veracyte's expenses were approximately three times higher than ADMA's. Notably, Veracyte's SG&A expenses surged by over 350% from 2014 to 2023, reflecting its aggressive growth strategy. Meanwhile, ADMA Biologics, Inc. exhibited a steady increase, with expenses rising by over 1,100% during the same period. This financial trajectory highlights the contrasting strategies of these companies, with Veracyte focusing on rapid expansion and ADMA on sustainable growth.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Veracyte, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Comparing SG&A Expenses: Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Breaking Down SG&A Expenses: Veracyte, Inc. vs Viridian Therapeutics, Inc.